A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) alternating with pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): Preliminary results from the t-cell consortium trial Meeting Abstract
| Authors: | Advani, R. H.; Ansell, S. M.; Lechowicz, M. J.; Beaven, A. W.; Loberiza, F. R. Jr; Carson, K. R.; Evens, A. M.; Foss, F. M.; Horwitz, S. M.; Pro, B.; Pinter-Brown, L.; Smith, S. M.; Shustov, A. R.; Savage, K. J.; Vose, J. M. |
| Abstract Title: | A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) alternating with pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): Preliminary results from the t-cell consortium trial |
| Meeting Title: | 55th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 122 |
| Issue: | 21 |
| Meeting Dates: | 2013 Dec 7-10 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2013-11-15 |
| Language: | English |
| ACCESSION: | WOS:000331385006315 |
| PROVIDER: | Clarivate Analytics Web of Science |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V122.21.3044.3044 |
| Notes: | Meeting Abstract: 3044 -- New Orleans, LA -- Source: Wos |
